Cargando…

Varying effects of common tuberculosis drugs on enhancing clofazimine activity in vitro

Detalles Bibliográficos
Autores principales:	Zhang, Shuo, Shi, Wanliang, Feng, Jie, Zhang, Wenhong, Zhang, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457683/ https://www.ncbi.nlm.nih.gov/pubmed/28442751 http://dx.doi.org/10.1038/emi.2017.24

Ejemplares similares

Identification of drug candidates that enhance pyrazinamide activity from a clinical compound library
por: Niu, Hongxia, et al.
Publicado: (2017)

Mutation in clpC1 encoding an ATP-dependent ATPase involved in protein degradation is associated with pyrazinamide resistance in Mycobacterium tuberculosis
por: Zhang, Shuo, et al.
Publicado: (2017)

Clofazimine induced methemoglobinemia – Points to be focussed
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Persister mechanisms in Borrelia burgdorferi: implications for improved intervention
por: Feng, Jie, et al.
Publicado: (2015)

Clofazimine for the treatment of tuberculosis
por: Stadler, Jacob A. M., et al.
Publicado: (2023)

Activity of Sulfa Drugs and Their Combinations against Stationary Phase B. burgdorferi In Vitro
por: Feng, Jie, et al.
Publicado: (2017)

Clofazimine: A potential therapeutic option for severe COVID-19
por: Ateya, Areej Mohamed
Publicado: (2021)

Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis
por: Shi, Wanliang, et al.
Publicado: (2014)

Rv1453 is associated with clofazimine resistance in Mycobacterium tuberculosis
por: Zhang, Lei, et al.
Publicado: (2023)

Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis
por: Zhang, Shuo, et al.
Publicado: (2013)

Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis
por: Sonnenkalb, Lindsay, et al.
Publicado: (2023)

Crystalline deposition in the cornea and conjunctiva secondary to long-term clofazimine therapy in a leprosy patient
por: Barot, Rakesh K, et al.
Publicado: (2011)

A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library
por: Feng, Jie, et al.
Publicado: (2016)

Investigation of Clofazimine Resistance and Genetic Mutations in Drug-Resistant Mycobacterium tuberculosis Isolates
por: Park, Sanghee, et al.
Publicado: (2022)

Bedaquiline, Delamanid, Linezolid, and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis
por: Padmapriyadarsini, Chandrasekaran, et al.
Publicado: (2022)

Clofazimine, but Not Isoniazid or Rifampicin, Augments Platelet Activation in vitro
por: Anderson, Ronald, et al.
Publicado: (2018)

Identification of Anti-Persister Activity against Uropathogenic Escherichia coli from a Clinical Drug Library
por: Niu, Hongxia, et al.
Publicado: (2015)

A Clinical Drug Library Screen Identifies Tosufloxacin as Being Highly Active against Staphylococcus aureus Persisters
por: Niu, Hongxia, et al.
Publicado: (2015)

Spontaneous mutational patterns and novel mutations for bedaquiline and clofazimine resistance in Mycobacterium tuberculosis
por: Shi, Jin, et al.
Publicado: (2023)

Adapting Clofazimine for Treatment of Cutaneous Tuberculosis by Using Self-Double-Emulsifying Drug Delivery Systems
por: van Staden, Daniélle, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis
por: Zhang, Cindy X., et al.
Publicado: (2022)

Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library
por: Feng, Jie, et al.
Publicado: (2015)

In Vitro Activity and Clinical Outcomes of Clofazimine for Nontuberculous Mycobacteria Pulmonary Disease
por: Kim, Dae Hun, et al.
Publicado: (2021)

Acquisition of Cross-Resistance to Bedaquiline and Clofazimine following Treatment for Tuberculosis in Pakistan
por: Ghodousi, Arash, et al.
Publicado: (2019)

Encapsulation of Clofazimine by Cyclodextran: Preparation, Characterization, and In Vitro Release Properties
por: Hong, Seong-Jin, et al.
Publicado: (2023)

Clofazimine-induced Hair Pigmentation
por: Philip, Mariam, et al.
Publicado: (2012)

The Transcription Factor Rv1453 Regulates the Expression of qor and Confers Resistant to Clofazimine in Mycobacterium tuberculosis
por: Li, Yuanyuan, et al.
Publicado: (2021)

Identification of new compounds with high activity against stationary phase Borrelia burgdorferi from the NCI compound collection
por: Feng, Jie, et al.
Publicado: (2015)

Identification of Genes Involved in Bacteriostatic Antibiotic-Induced Persister Formation
por: Cui, Peng, et al.
Publicado: (2018)

Pyrazinoic Acid Inhibits the Bifunctional Enzyme (Rv2783) in Mycobacterium tuberculosis by Competing with tmRNA
por: He, Lei, et al.
Publicado: (2019)

Design and Solidification of Fast-Releasing Clofazimine Nanoparticles for Treatment of Cryptosporidiosis
por: Zhang, Yingyue, et al.
Publicado: (2017)

Mannose receptor targeted bioadhesive chitosan nanoparticles of clofazimine for effective therapy of tuberculosis
por: Pawde, Datta Maroti, et al.
Publicado: (2020)

Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial
por: Zheng, Xubin, et al.
Publicado: (2023)

Anti-Tuberculosis Activity of Three Carbapenems, Clofazimine and Nitazoxanide Using a Novel Ex Vivo Phenotypic Drug Susceptibility Model of Human Tuberculosis
por: Gonzalo, Ximena, et al.
Publicado: (2022)

Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library
por: Feng, Jie, et al.
Publicado: (2014)

Extensively Drug-Resistant Tuberculosis, China
por: Tang, Shenjie, et al.
Publicado: (2011)

Dually Acting Nonclassical 1,4-Dihydropyridines Promote the Anti-Tuberculosis (Tb) Activities of Clofazimine
por: Lentz, Fabian, et al.
Publicado: (2019)

Drug-resistant Mycobacterium tuberculosis, Taiwan
por: Jou, Ruwen, et al.
Publicado: (2006)

Clofazimine for Rapidly Growing Mycobacterial Infections
por: Carey, George B, et al.
Publicado: (2017)

Clofazimine induced pigmentation in leprosy patches
por: Chavhan, Samiksha Deepak, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ct3upevjmttcgrat295hi74dju